Warning Letter Roundup: FDA Warns Drugmakers for Variety of Issues

The FDA slapped three drug manufacturers — including two Chinese firms — with warning letters after the agency’s inspections revealed a wide range of issues at the facilities, such as adulterated products and the lack of a quality unit.
Source: Drug GMP Report